Core Viewpoint - Cosmos Health Inc. has announced that its CEO, Greg Siokas, has significantly increased his ownership stake in the company by acquiring 1,466,764 common shares valued at $526,000, reflecting his confidence in the company's future prospects [1][2][3] Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada, focusing on innovative R&D and owning proprietary pharmaceutical and nutraceutical brands [5] - The company manufactures and distributes healthcare products and operates a telehealth platform, with a global distribution network expanding throughout Europe, Asia, and North America [5] Recent Transactions - Greg Siokas has invested over $1.3 million in the past five months, increasing his total ownership to 5,582,066 common shares, with a cumulative investment exceeding $18 million since the company's inception [2][3] Product and Service Offerings - Cosmos Health owns a portfolio of brands including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept®, and C-Scrub®, and manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices under European Good Manufacturing Practices [5] - The company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, utilizing artificial intelligence for drug repurposing and focusing on novel patented nutraceuticals and innovative OTC products [5]
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000